Univar Solutions Inc. today announced the appointment of Nicholas W. Alexos as executive vice president and chief financial officer, effective January 6, 2020. Nick will succeed Carl J. Lukach who will transition into the role of executive vice president of corporate development.
“Nick is a seasoned financial executive with extensive and relevant experience from his prior roles at Dentsply Sirona and VWR International,” said David Jukes, president and chief executive officer. “Given his in-depth knowledge and expertise around market and margin expansion in the general industrial and consumer sectors, Nick will be a perfect addition to the Company as we continue to drive profitable growth and shareholder value over the long term.”
Nick joins Univar Solutions after serving as executive vice president, chief financial officer and chief administrative officer at Dentsply Sirona, Inc. where he led key growth strategies and successfully executed portfolio shaping initiatives. Previously he served as a managing director of Madison Dearborn Partners, LLC, where he helped a wide array of portfolio companies achieve growth and margin expansion.
Carl will transition duties to Nick as he begins his new role, while assuming the role of executive vice president of corporate development. In this role, Carl is expected to oversee the Company’s portfolio management activities, as well as generate new growth opportunities. He will also help support various efficiency initiatives related to the Nexeo integration and will continue to report to David Jukes.
“I want to thank Carl for his many contributions as CFO and I look forward to working with he and Nick in their new roles,” said Jukes. “Univar Solutions is well-positioned to take advantage of market opportunities as we continue to streamline, innovate and grow the Company to redefine distribution and be the most valued chemical and ingredient distributor on the planet.”
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.